ATLAS OF LIQUID BIOPSY CIRCULATING TUMOR CELLS AND OTHER RARE CELLS IN CANCER PATIENTS’ BLOOD (HB 2021) at Meripustak

ATLAS OF LIQUID BIOPSY CIRCULATING TUMOR CELLS AND OTHER RARE CELLS IN CANCER PATIENTS’ BLOOD (HB 2021)

Books from same Author: Ludmilla Thome Domingos Chinen

Books from same Publisher: Springer Nature Switzerland AG

Related Category: Author List / Publisher List


  • Retail Price: ₹ 15631/- [ 0.00% off ]

    Seller Price: ₹ 15631

Sold By: T K Pandey      Click for Bulk Order

Offer 1: Get ₹ 111 extra discount on minimum ₹ 500 [Use Code: Bharat]

Offer 2: Get 0.00 % + Flat ₹ 100 discount on shopping of ₹ 1500 [Use Code: IND100]

Offer 3: Get 0.00 % + Flat ₹ 300 discount on shopping of ₹ 5000 [Use Code: MPSTK300]

Free Shipping (for orders above ₹ 499) *T&C apply.

In Stock

Free Shipping Available



Click for International Orders
  • Provide Fastest Delivery

  • 100% Original Guaranteed
  • General Information  
    Author(s)Ludmilla Thome Domingos Chinen
    PublisherSpringer Nature Switzerland AG
    Edition1st ed. 2021
    ISBN9783030698782
    Pages204
    BindingHardback
    LanguageEnglish
    Publish YearJune 2021

    Description

    Springer Nature Switzerland AG ATLAS OF LIQUID BIOPSY CIRCULATING TUMOR CELLS AND OTHER RARE CELLS IN CANCER PATIENTS’ BLOOD (HB 2021) by Ludmilla Thome Domingos Chinen

    This book provides a wealth of images and extensive information on circulating tumor cells (CTCs) and other cells usually observed in blood from patients with cancer such as giant macrophages and circulating tumor microemboli (CTM).The field of liquid biopsy began with the analysis of CTCs in the early 2000s. In the beginning molecular techniques were developed to detect these cells in the blood. However it has since become clear that CTCs initially require a cytopathological analysis to be detected without false positive and negative results. After detection molecular analysis can be subsequently performed.Cancer is an important cause of mortality especially when detected in late stages. Even with all the advances that have been made in its treatment cancer is still challenging as many patients do not respond to any therapy. Many health agencies have considered early diagnosis as a feasible tool. In this context it is of the utmost importance to know the morphology and characteristics of CTCs to determine a correct diagnosis. Currently much of the scientific community is committed to expanding our knowledge of CTCs and this work makes a valuable contribution presenting hundreds of cell images from patients with various types of cancer in many different stages of disease and after receiving various treatments.The Atlas of Liquid Biopsy: Circulating Tumor Cells and Other Rare Cells in Cancer Patients Blood is an essential reference guide for all physicians biologists biomedics and professionals working at clinical and research laboratories hospitals and research centers.